comparemela.com

Swedish Orphan Biovitrum Ab Publ Stock Exchange News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Swedish Orphan Biovitrum : Changes to Sobi s management

Changes to Sobi s management 19 June, 2023 14:45 Tony Hoos, Head of R&D and Medical Affairs , and Chief Medical Officer , is leaving. | June 19, 2023

United statesTony hoosAnders ullmanGuido oelkersLydia abad franchSobi executive committeeMedical affairsChief medical officerClinical scienceBoard memberNorth americaMiddle eastSwedish orphan biovitrum ab publ stock exchangePress releaseS sobi se0000872095

Swedish Orphan Biovitrum : Sobi to relocate its global headquarters in Stockholm, Sweden

We are pleased to announce the relocation of our global headquarters to the Fenix Sthlm building in Hagastaden, Stockholm, Sweden. With this move, we will continue to be in an international. | May 31, 2023

Christine wesstrFenix sthlmGlobal technical operationsFacilities swedenSwedish orphan biovitrum ab publ stock exchangePress releaseN sobi se0000872095

Swedish Orphan Biovitrum : 10 May – Acquisition CTI Biopharma

Acquisition of CTI Biopharma Expanding Sobi s position in rare haematology . | May 15, 2023

Swedish orphan biovitrum ab publ stock exchangePress releaseAre sobi se0000872095

Swedish Orphan Biovitrum : 27 april – Q1 2023 rapport

Q1 2023 report Conference call for investors and analysts . | April 27, 2023

United statesSafe harborSwedish orphan biovitrumSwedish orphan biovitrum ab publ stock exchangePress releaseNd sobi se0000872095

Invitation: Sobi s Q1 2023 report | MarketScreener

Invitation: Sobi s Q1 2023 report 19 April, 2023 11:00 Sobi plans to publish its report for the first quarter of 2023 on 27 April 2023 at. | April 19, 2023

United kingdomUnited statesNorth americaMiddle eastSwedish orphan biovitrum ab publ stock exchangePress release023 sobi se0000872095

vimarsana © 2020. All Rights Reserved.